CEL Celadon Pharmaceuticals Plc

61.00

1.50 (2.52%)

22 Jul 2024 - Closed

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Celadon Pharmaceuticals Plc	LSE:CEL	London	Ordinary Share	GB00BDQYGP38	ORD 1P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	1.50	2.52%	61.00	57.00	65.00	61.00	59.50	59.50	12,246	14:00:11

Industry Sector	Turnover	Profit	EPS - Basic	PE Ratio	Market Cap
Investment Advice	149k	-7.14M	-0.1082	-5.64	39.26M

Director/PDMR Shareholding

29/08/2007 3:17pm

UK Regulatory

RNS Number:9444C
Celsis International PLC
29 August 2007

                            Celsis International plc
                                ("the Company")


                           Director/PDMR Shareholding


29 August 2007: The Company was notified on 28 August 2007 that on 14 August
2007 Mrs Sue Rowell, the spouse of Dr Jack Rowell, Non-Executive Chairman of the
Company, purchased 3,455 ordinary shares of 5 pence each in the Company
("Ordinary Shares") at an average price of 201 pence per Ordinary Share.


Following these purchases Mrs Rowell's beneficial interest in the Company is
3,455 Ordinary Shares, representing a total of 0.02 per cent. of the issued
share capital of the Company.




Enquiries:
Celsis International plc                                      Tel: 01223 598 428
Christian Madrolle, Finance Director and Company Secretary
Jenny Parsons, Corporate Communications
Financial Dynamics                                            Tel: 020 7831 3113
David Yates

Ben Atwell






                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

RDSBXGDISSDGGRC